Evidence map›Paper›PMID 29180410›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Smek1/2 is a nuclear chaperone and cofactor for cleaved Wnt receptor Ryk, regulating cortical neurogenesis.

Wen-Hsuan Chang, Si Ho Choi, Byoung-San Moon, Mingyang Cai, Jungmook Lyu, Jinlun Bai, Fan Gao, Ibrahim Hajjali, Zhongfang Zhao, Daniel B Campbell and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Wen-Hsuan ChangThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Si Ho ChoiThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033; sihochoi@dirams.re.kr wangelu@usc.edu.
Byoung-San MoonThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Mingyang CaiThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Jungmook LyuThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Jinlun BaiThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Fan GaoThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Ibrahim HajjaliThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033.
Zhongfang ZhaoCollege of Life Sciences, Nankai University, Tianjin 300071, China.
Daniel B CampbellZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA 90033.
Leslie P WeinerZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA 90033.
Wange LuThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of Southern California, Los Angeles, CA 90033; sihochoi@dirams.re.kr wangelu@usc.edu.
University of Southern California · USBroad Center · USKonyang University · KRNankai University · CN

Funding

Training in Developmental Biology, Stem Cells and RegenerationT32HD060549 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Gage D Crump · 2011 to 2026
$2.5M
Molecular Mechanisms of Neuronal DifferentiationR01NS067213 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, WANGE · 2010 to 2014
$1.7M
NICHD NIH HHS T32 HD060549NINDS NIH HHS R01 NS067213
6 · The paper itself

Abstract

The receptor-like tyrosine kinase (Ryk), a Wnt receptor, is important for cell fate determination during corticogenesis. During neuronal differentiation, the Ryk intracellular domain (ICD) is cleaved. Cleavage of Ryk and nuclear translocation of Ryk-ICD are required for neuronal differentiation. However, the mechanism of translocation and how it regulates neuronal differentiation remain unclear. Here, we identified Smek1 and Smek2 as Ryk-ICD partners that regulate its nuclear localization and function together with Ryk-ICD in the nucleus through chromatin recruitment and gene transcription regulation. Smek1/2 double knockout mice displayed pronounced defects in the production of cortical neurons, especially interneurons, while the neural stem cell population increased. In addition, both Smek and Ryk-ICD bound to the Dlx1/2 intergenic regulator element and were involved in its transcriptional regulation. These findings demonstrate a mechanism of the Ryk signaling pathway in which Smek1/2 and Ryk-ICD work together to mediate neural cell fate during corticogenesis.

Indexed as

AnimalsCell NucleusCells, CulturedCoenzymesHEK293 CellsHumansMiceMolecular ChaperonesNeurogenesisPhosphoprotein PhosphatasesReceptor Protein-Tyrosine KinasesCoenzymesMolecular ChaperonesPhosphoprotein PhosphatasesPpp4r3a protein, mouseReceptor Protein-Tyrosine KinasesRyk protein, mouseSmek2 protein, mouseneural stem cellneurogenesisnoncanonical Wnt signalingRyk signaling

Identifiers

PMID29180410
PMCPMC5740651
OpenAlexW2769228139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.